期刊文献+

Association between non-alcoholic fatty liver disease and coronary artery disease severity 被引量:18

Association between non-alcoholic fatty liver disease and coronary artery disease severity
原文传递
导出
摘要 Background Both non-alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD) are closely associated with many metabolic disorders. Invasive coronary angiography (CAG) is a common approach as an intervention for CAD.However, the association between angiographic severity of coronary artery and NAFLD remains controversial. This study aimed to evaluate the relationship between NAFLD and CAD.Methods Totally 542 consecutive patients who planned to undergo CAG due to a suspected CAD were enrolled.Abdominal computed tomography (CT) was performed before angiography to detect NAFLD. CAD was defined as stenosis of at least 50% in at least one major coronary artery. The severity of CAD was assessed by the number of vessels affected and the vessel score multiplied by the severity score (Gensini score). Significant stenosis was defined as 70% or greater reduction in lumen diameter. A probability value of P 〈0.05 was considered statistically significant.Results Of 542 patients studied, 248 (45.8%) were found to have NAFLD by abdominal CT, and 382 patients (88%)were found to have significant CAD by CAG. Age, diabetes mellitus, waist circumference, body mass index, and obesity were associated with NAFLD. According to the results of Logistic regression analysis, the presence of NAFLD independently increased the risk for CAD, as seen in CAG (odds ratio (OR), 95% confidence interval (CI): 7.585(4.617-12.461); P 〈0.001). NAFLD was significantly more common in patients as CAD severity increased (P〈0.001).Conclusions The presence of NAFLD is associated with high severity of CAD, requiring that patients with abdominal obesity be also investigated for NAFLD. Patients with NAFLD should be closely followed up for the presence and severity of CAD. Background Both non-alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD) are closely associated with many metabolic disorders. Invasive coronary angiography (CAG) is a common approach as an intervention for CAD.However, the association between angiographic severity of coronary artery and NAFLD remains controversial. This study aimed to evaluate the relationship between NAFLD and CAD.Methods Totally 542 consecutive patients who planned to undergo CAG due to a suspected CAD were enrolled.Abdominal computed tomography (CT) was performed before angiography to detect NAFLD. CAD was defined as stenosis of at least 50% in at least one major coronary artery. The severity of CAD was assessed by the number of vessels affected and the vessel score multiplied by the severity score (Gensini score). Significant stenosis was defined as 70% or greater reduction in lumen diameter. A probability value of P 〈0.05 was considered statistically significant.Results Of 542 patients studied, 248 (45.8%) were found to have NAFLD by abdominal CT, and 382 patients (88%)were found to have significant CAD by CAG. Age, diabetes mellitus, waist circumference, body mass index, and obesity were associated with NAFLD. According to the results of Logistic regression analysis, the presence of NAFLD independently increased the risk for CAD, as seen in CAG (odds ratio (OR), 95% confidence interval (CI): 7.585(4.617-12.461); P 〈0.001). NAFLD was significantly more common in patients as CAD severity increased (P〈0.001).Conclusions The presence of NAFLD is associated with high severity of CAD, requiring that patients with abdominal obesity be also investigated for NAFLD. Patients with NAFLD should be closely followed up for the presence and severity of CAD.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第6期867-872,共6页 中华医学杂志(英文版)
关键词 non-alcoholic fatty liver disease coronary artery disease computed tomography non-alcoholic fatty liver disease coronary artery disease computed tomography
  • 相关文献

参考文献2

二级参考文献68

  • 1[1]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003; 37:1202-1219
  • 2[2]Bellentani S,Saccoccio G,Masutti F,Croce LS,Brandi G,Sasso F,Cristanini G,Tiribelli C.Prevalence of and risk factors for hepatic steatosis in Northern Italy.Ann Intern Med 2000;132:112-117
  • 3[3]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Morton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 4[4]Chitturi S,Farrell GC,George J.Non-alcoholic steatohepatitis in the Asia-Pacific region:future shock? J Gastroenterol Hepatol 2004; 19:368-374
  • 5[5]Akbar DH,Kawther AH.Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic:prevalence and general characteristics.Diabetes Care 2003; 26:3351-3352
  • 6[6]Gupte P,Amarapurkar D,Agal S,Baijal R,Kulshrestha P,Pramanik S,Patel N,Madan A,Amarapurkar A,Hafeezunnisa.Non-alcoholic steatohepatitis in type 2 diabetes mellitus.J Gastroenterol Hepatol 2004; 19:854-858
  • 7[7]Assy N,Kaita K,Mymin D,Levy C,Rosser B,Minuk G.Fatty infiltration of liver in hyperlipidemic patients.Dig Dis Sci 2000; 45:1929-1934
  • 8[8]Donati G,Stagni B,Piscaglia F,Venturoli N,Morselli-Labate AM,Rasciti L,Bolondi L.Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes:role of insulin resistance.Gut 2004; 53:1020-1023
  • 9[9]Hamaguchi M,Kojima T,Takeda N,Nakagawa T,Taniguchi H,Fujii K,Omatsu T,Nakajima T,Sarui H,Shimazaki M,Kato T,Okuda J,Ida K.The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med 2005; 143:722-778
  • 10[10]Isomaa B,Almgren P,Tuomi T,Forsen B,Lahti K,Nissen M,Taskinen MR,Groop L.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care 2001; 24:683-689

共引文献61

同被引文献63

引证文献18

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部